Stellar Biotechnologies

hab nach Jahren wieder mal reingeschaut: "The net loss for the fiscal year ended September 30, 2015 was $2.8 million, or ($0.36) per share, as compared to a net loss of $8.4 million, or ($1.11) per share, for the fiscal year 2014." die bottom line des 2015er reports v. 14 Dez sieht ja nicht so toll aus... LG keyar

Stellar Biotechnologies and Biovest International Sign KLH Supply Agreement for BiovaxID Immunotherapy for Follicular Non-Hodgkin's Lymphoma http://ir.stellarbiotechnologies.com/press-releases/detail/234 Es tut sich langsam was....

... endlich ein Kursfeuerwerk. Und der Laden steht auch finianziell wohl bestens da. Jetzt fehlen nur noch die FDA-Zulassungen der Pharma-Kunden von Stallar und dann kommt hier so richtig Feuer ins Spiel. Dies dürfte aber noch ein paar Monate bzw. wenige Jahre dauern... Ich freu mich jedenfalls

Stellar Biotech director, finance VP Brookstein resigns 2013-06-21 16:35 ET - News Release Mr. Frank Oakes reports STELLAR BIOTECHNOLOGIES ANNOUNCES RESIGNATION OF BOARD MEMBER Darrell Brookstein has resigned from his role as executive vice-president, corporate development and finance, and from his position on Stellar Biotechnologies Inc.'s board of directors, effective June 21, 2013. Mr. Brookstein has served on the board since April, 2010. He is resigning to devote more time to personal and outside business commitments. "Stellar is a great company with very attractive growth potential," said Mr. Brookstein. "I believe the path laid out for the company's future is well thought out and contains the seeds for greater success. I am very confident in the company's prospects, and I remain supportive of its progress and the board's good efforts, in any way possible." Frank Oakes, Stellar chairman, said: "On behalf of the board, we want to thank Darrell for his contributions as executive VP and a director of the company. Darrell was instrumental in the company's early structuring and its transformation into a publicly held corporation. We appreciate his thoughtful input to Stellar's business strategy and his passion for our technology. We wish Darrell well in his future activities." We seek Safe Harbor.